{"id":663,"date":"2014-10-16T10:52:31","date_gmt":"2014-10-16T14:52:31","guid":{"rendered":"http:\/\/caloriecontrol.wpengine.com\/?p=663"},"modified":"2020-01-27T17:48:09","modified_gmt":"2020-01-27T22:48:09","slug":"fructose-consumption-research-not-based-on-realistic-levels-and-is-contrary-to-many-other-studies","status":"publish","type":"post","link":"https:\/\/caloriecontrol.org\/fructose-consumption-research-not-based-on-realistic-levels-and-is-contrary-to-many-other-studies\/","title":{"rendered":"Fructose Consumption Research Not Based On Realistic Levels, and is Contrary to Many Other Studies"},"content":{"rendered":"

ATLANTA (October 16, 2014) \u2014 A new study which claims that fructose may play a unique role in the development of obesity and diabetes is limited by several study flaws, including contradicting research, exaggerated consumption levels, small sample size and reliance on animal research.<\/p>\n

In the 21-person study \u201cFructose ingestion acutely stimulates circulating FGF21 levels in humans\u201d, research subjects — some healthy and some with metabolic syndrome — <\/strong>participated in three trials in which they consumed one of three beverages made up of either fructose, glucose or a combination. After consumption, blood samples were taken with researchers looking for impact on the fibroblast growth factor 21 (FGF21), a recently discovered hormone produced in the liver and in fat tissue. Previous research has hypothesized that FGF21 may play a role in glucose and fat homeostasis in rodents and researchers in this study tested this hypothesis in humans. (More about the study located here<\/a><\/b>.)  Researchers concluded that FGF21 may be involved in fructose metabolism and that fructose may be associated with metabolic disorders such as diabetes.<\/p>\n

However, the study suffered from several limitations that hamper the generalizability of the findings, including:<\/p>\n